Key points are not available for this paper at this time.
These findings suggest that a raised serum GGT level is an independent risk factor for NIDDM. Serum GGT level may be a simple and reliable marker of visceral and hepatic fat and, by inference, of hepatic insulin resistance.
Perry et al. (Fri,) studied this question.